
Artificial Intelligence (AI)-Powered Acute Stroke Triage Market Report 2026
Global Outlook – By Component (Software, Hardware, Services ), By Deployment Mode (On-Premises, Cloud-Based ), By Application (Hospitals, Diagnostic Centers, Emergency Medical Services, Research Institutes, Other Applications), By End-User (Healthcare Providers, Radiology Centers, Academic And Research Institutes, Other End-Users) - Market Size, Trends, And Global Forecast 2026-2035
Artificial Intelligence (AI)-Powered Acute Stroke Triage Market Overview
• Artificial Intelligence (AI)-Powered Acute Stroke Triage market size has reached to $1.72 billion in 2025 • Expected to grow to $4.67 billion in 2030 at a compound annual growth rate (CAGR) of 22% • Growth Driver: Rising Incidence Of Stroke Fueling The Growth Of The Market Due To Increasing Hypertension And Urgent Need For Rapid Diagnosis • Market Trend: AI Algorithms Enhance Accuracy And Triage Speed • North America was the largest region in 2025.What Is Covered Under Artificial Intelligence (AI)-Powered Acute Stroke Triage Market?
Artificial intelligence (AI)-powered acute stroke triage is a medical technology that leverages AI algorithms to rapidly analyze brain imaging and patient data for suspected stroke cases. Its primary purpose is to identify stroke type, severity, and the presence of large vessel occlusions in real time, enabling faster clinical decision-making. The main components of artificial intelligence (AI)-powered acute stroke triage are software, hardware, and services. Software refers to artificial intelligence (AI)-driven programs that automatically evaluate brain scan images, identify stroke indicators, prioritize critical cases, and help healthcare professionals make quicker treatment decisions. It is deployed through on-premises and cloud-based modes, and has applications in various sectors such as hospitals, diagnostic centers, emergency medical services, research institutes, and others. The key end users include healthcare providers, radiology centers, academic and research organizations, and others.
What Is The Artificial Intelligence (AI)-Powered Acute Stroke Triage Market Size and Share 2026?
The artificial intelligence (ai)-powered acute stroke triage market size has grown exponentially in recent years. It will grow from $1.72 billion in 2025 to $2.11 billion in 2026 at a compound annual growth rate (CAGR) of 22.3%. The growth in the historic period can be attributed to increasing incidence of acute stroke cases, expansion of advanced imaging infrastructure, growing adoption of clinical decision support systems, rising investments in emergency care technology, improvements in machine learning accuracy.What Is The Artificial Intelligence (AI)-Powered Acute Stroke Triage Market Growth Forecast?
The artificial intelligence (ai)-powered acute stroke triage market size is expected to see exponential growth in the next few years. It will grow to $4.67 billion in 2030 at a compound annual growth rate (CAGR) of 22.0%. The growth in the forecast period can be attributed to increasing demand for faster stroke diagnosis, rising investments in ai-enabled emergency care, expansion of telestroke networks, growing focus on outcome-based healthcare, advancements in real-time medical analytics. Major trends in the forecast period include increasing adoption of AI-based imaging analysis, growing integration of real-time stroke alert systems, rising use of predictive clinical decision tools, expansion of cloud-based imaging platforms, enhanced focus on time-critical care optimization.Global Artificial Intelligence (AI)-Powered Acute Stroke Triage Market Segmentation
1) By Component: Software, Hardware, Services 2) By Deployment Mode: On-Premises, Cloud-Based 3) By Application: Hospitals, Diagnostic Centers, Emergency Medical Services, Research Institutes, Other Applications 4) By End-User: Healthcare Providers, Radiology Centers, Academic And Research Institutes, Other End-Users Subsegments: 1) By Software: Clinical Decision Support Software, Imaging And Diagnostics Software, Workflow Management Software, Data Integration And Interoperability Platforms, Predictive Analytics And Machine Learning Tools 2) By Hardware: Medical Imaging Devices, Edge Computing Devices, AI Processing Units, Workstations And Servers, Networking And Storage Devices 3) By Services: Implementation And Integration Services, Training And Education Services, Maintenance and Support Services, Consulting Services, Cloud-Based Deployment and Managed ServicesWhat Is The Driver Of The Artificial Intelligence (AI)-Powered Acute Stroke Triage Market?
The rising incidence of stroke is expected to propel the growth of the artificial intelligence (AI)-powered acute stroke triage market going forward. A stroke refers to a condition where interrupted blood flow to the brain causes cell damage, leading to potential disability or death if not treated quickly. The rising incidence of stroke is due to hypertension, as high blood pressure increases the risk of brain vessel blockages or ruptures. Artificial intelligence (AI)-powered acute stroke triage helps in stroke diagnosis by rapidly analyzing brain scans, making it crucial for early detection of stroke type and severity. They reduce diagnostic delays by prioritizing urgent cases, improving treatment speed and patient outcomes. For instance, in September 2024, according to the Stroke Foundation, an Australia-based non-profit organization, in 2023, around 45,785 Australians experienced a stroke, averaging one stroke every 11 minutes, with 34,793 of these being first-time occurrences. Therefore, the rising incidence of stroke is driving the growth of the artificial intelligence (AI)-powered acute stroke triage industry.Key Players In The Global Artificial Intelligence (AI)-Powered Acute Stroke Triage Market
Major companies operating in the artificial intelligence (AI)-powered acute stroke triage market are Siemens Healthineers AG, GE HealthCare Technologies Inc., Shanghai United Imaging Healthcare Co. Ltd., Viz.ai Inc., Aidoc Medical Ltd., RapidAI Inc., Qure.ai Technologies Private Limited, Harrison.ai Pty Ltd, Infervision Inc., Circle Cardiovascular Imaging Inc., Behold.ai Ltd., Brainomix Ltd., JLK Inc., BioMind.ai Pte. Ltd., Sevaro Health Inc., Heuron Technologies Inc., Nicolab Inc., icometrix NV, Deep01 Inc., SNAC Medical Inc., BrainScan.ai Ltd., Cercare Medical Ltd., Avicenna.AI GmbHGlobal Artificial Intelligence (AI)-Powered Acute Stroke Triage Market Trends and Insights
Major companies operating in the artificial intelligence (AI)-powered acute stroke triage market are focusing on developing technologically advanced solutions, such as advanced artificial intelligence (AI) algorithms, to improve diagnostic accuracy, accelerate triage, and enhance clinical outcomes. Advanced artificial intelligence (AI) algorithms refer to complex computational methods that learn from data to recognize patterns, make predictions, and support intelligent decision-making. For instance, in April 2023, RapidAI Inc., a US-based provider of cerebrovascular imaging solutions, received United States Food and Drug Administration (FDA) 510(k) clearance for Rapid Noncontrast Computed Tomography (NCCT) Stroke, an artificial intelligence (AI) solution for non-contrast CT imaging to detect suspected intracranial hemorrhage (ICH) and large vessel occlusion (LVO) from standard CT scans. This system automatically analyzes NCCT images, delivering triage and prioritization alerts via PACS, email, and the Rapid mobile app, enabling faster door-to-imaging and door-to-decision times. It also supports rapid transfer and treatment decisions, reduces delays for advanced imaging, and enhances access to advanced stroke care at hospitals of all levels.What Are Latest Mergers And Acquisitions In The Artificial Intelligence (AI)-Powered Acute Stroke Triage Market?
In February 2023, Bayer AG, a Germany-based life sciences company, acquired Blackford Analysis Ltd. for an undisclosed amount. With this acquisition, Blackford aims to enhance AI-driven radiology by combining Blackford’s imaging platform with Bayer’s global resources, improving clinical workflows, diagnostic efficiency, and patient care while preserving innovation. Blackford Analysis Ltd. is a UK-based company that provides AI-powered imaging solutions for acute stroke triage.Regional Outlook
North America was the largest region in the artificial intelligence (AI)-powered acute stroke triage market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Artificial Intelligence (AI)-Powered Acute Stroke Triage Market?
The artificial intelligence (AI)-powered acute stroke triage market includes revenues earned by entities by providing services such as real-time stroke detection and analysis, automated imaging interpretation, clinical decision support, tele-radiology consultations, and workflow optimization for rapid treatment initiation. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-powered acute stroke triage market also includes sales of computed tomography (CT) scanners, magnetic resonance imaging (MRI) machines, integrated stroke detection systems, and cloud-based triage solutions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Artificial Intelligence (AI)-Powered Acute Stroke Triage Market Report 2026?
The artificial intelligence (ai)-powered acute stroke triage market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (ai)-powered acute stroke triage industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Artificial Intelligence (AI)-Powered Acute Stroke Triage Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.11 billion |
| Revenue Forecast In 2035 | $4.67 billion |
| Growth Rate | CAGR of 22.3% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Component, Deployment Mode, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Siemens Healthineers AG, GE HealthCare Technologies Inc., Shanghai United Imaging Healthcare Co. Ltd., Viz.ai Inc., Aidoc Medical Ltd., RapidAI Inc., Qure.ai Technologies Private Limited, Harrison.ai Pty Ltd, Infervision Inc., Circle Cardiovascular Imaging Inc., Behold.ai Ltd., Brainomix Ltd., JLK Inc., BioMind.ai Pte. Ltd., Sevaro Health Inc., Heuron Technologies Inc., Nicolab Inc., icometrix NV, Deep01 Inc., SNAC Medical Inc., BrainScan.ai Ltd., Cercare Medical Ltd., Avicenna.AI GmbH |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
